Forms and Doses

The pages below cover the forms of palmitoylethanolamide used in research and the doses that published trials used.

• Micronised and ultramicronisedWhat the particle-size terms mean, the evidence that size changes absorption, and how often the trials say which form they used.
• Levagen and dispersion technologyWhat Levagen and Levagen+ are, the one absorption study behind the dispersion claim, and the trials that used them.
• Absorption studiesWhat is known, and not known, about how palmitoylethanolamide is absorbed, distributed and cleared.
• Doses used in published trialsThe doses that researchers used in each study in the database, by species. Not a dosing guide.
• Safety and interaction dataWhat the published trials and reviews report about adverse events, blood tests, drug interactions and long-term use of palmitoylethanolamide, and what has not been studied.
• Powder, capsule, tablet, sachet, creamThe physical forms used in the published palmitoylethanolamide trials, with the study behind each one.